Blaze Capital (@BlazeCapital) / Twitter
CYBN Stock Price and Chart — NEO:CYBN — TradingView
CEO.CA | #cybn CYBIN INC. (CYBN.NEO)
Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent
CYBIN INC. : CYBN Stock Price | CA23256X1006 | MarketScreener
Buy Cybin Stock | CYBN Stock Price Today & News | Public.com
Cilo Cybin Share Price | RNS News, Quotes, & Charts |
Psychedelic Stock Market Update May 2022: Are We At The Bottom? | Psychedelic Invest
CLXPF Stock Forecast, Price & News (Cybin)
Cybin vs Compass - comparisons to help explain the similarities and differences. : r/shroomstocks
Cybin Lands Conditional Approval To Become The First Psychedelics Company on The NYSE
What about CYBN? CYBN - Phase IIa trial of (CYB001-psilocybin) for Major Depressive Disorder. CMPS Phase llb trial of (COMP360-psilocybin) for Treatment Resistant Depression. CMPS Mkt cap $1.4B vs CYBN Mkt cap
VIDEO: How Is Cybin Taking On Mental Healthcare? | Benzinga Global Small Cap Conference
Psychedelic Stock Market Update May 2022: Are We At The Bottom? | Psychedelic Invest
Canaccord Gives Cybin 10x Price Target | Microdose
Buying Cybin Stock Right Now Could Be a Brilliant Move | The Motley Fool
Cybin: High-Risk, High-Reward Investment (OTCMKTS:CLXPF) | Seeking Alpha
Cybin: High-Risk, High-Reward Investment (OTCMKTS:CLXPF) | Seeking Alpha
Are Psychedelic Stocks the Next Big Thing? (NEO:MMED) (NEO:CYBN) (CNSX:FTRP) - Truffle Report %
Cybin (CYBN.NEO): Grown up approach to psychedelics brings half billion valuation... so far - Equity.Guru
CYBN stock gains on regulatory nod to study depression candidate (NYSE:CYBN) | Seeking Alpha
Cybin Inc (FRA:R7E1) Stock Price, Trades & News | GuruFocus
Cybin Inc Financial Statements – AMEX:CYBN – TradingView
Psychedelic Therapeutics Startup Cybin To List On NYSE's Small Cap Market
Big time uplistings this week for Cybin (CYBN.NE) and Field Trip (FTRP.C) - Equity.Guru
Psychedelic Stock Market Update May 2022: Are We At The Bottom? | Psychedelic Invest
Roth Capital Doubles Down on Cybin After DMT Acquisition | Microdose
Report: $CYBN $CLXPF (Cybin) to uplist to NASDAQ Q2 (ends June 30th?), with a Price Target $10.00 USD. (Seems very undervalued) : r/shroomstocks
